This Month in Psychopharmacology

Prenatal Development Not Impacted by ADHD Medication Use

As the diagnosis of adult attention-deficit/hyperactivity disorder ...

Read More

Perinatal Depression and Risk of Suicidal Behavior

Maternal suicide is a significant public health concern and the sec...

Read More

Role of Neuroactive Steroids and Brain Health

The classic neuropathological hypothesis and treatment basis (e.g....

Read More

FDA Approves First Oral Treatment for Postpartum Depression

The U.S. Food and Drug Administration has approved the zuranolone ...

Read More

2023 NEI Synapse: Sleep Issues During Pregnancy and Postpartum

At the 2023 NEI Synapse, Dr. Jade Wu presented a lecture on sleep d...

Read More

Folic Acid Tied to a Reduction in Suicide Attempts

Prescription folic acid was previously linked with decreased risk o...

Read More

Antidepressants in Pregnancy Aren't Linked to Increased Neurological Issues in Children

In a recent cohort study, the relationship between in utero exposur...

Read More

Treating ADHD During Breastfeeding

There is a lack of data regarding risks of stimulant and non-stimul...

Read More

Highlights From the 2022 NEI Synapse: Depression Throughout the Female Lifespan

At the 2022 NEI Synapse, Dr. Mary Kimmel discussed best practices f...

Read More

Risk of Depression Across Female Lifecycle

Estrogen levels shift rather dramatically across the female life cy...

Read More

Paternal Prevalence of Comorbid Depression and Anxiety During First Two Years Postpartum

A recent longitudinal cohort study examined the prevalence of pate...

Read More

Postpartum Anhedonia: Emergent Patterns in Bipolar and Unipolar Depression

Anhedonia, the lack of interest in previously pleasurable activitie...

Read More